Fluxus, Inc.
Peter Wagner is the President, Chief Executive Officer, and Co-Founder of Fluxus Inc. Peter is also the President and Founder of Coincident Biosciences LLC. With a background in biophysics and biochemistry, Peter has held various executive roles in companies such as S2 Genomics and Zyomyx, Inc. Prior to their corporate career, Peter conducted research as an Alexander-von-Humboldt Fellow at Stanford University School of Medicine and as a Postdoctoral Research Scientist at the Swiss Federal Institute of Technology (ETH).
Fluxus, Inc.
Fluxus Inc. is a privately held development-stage medical device company located in Sunnyvale, CA, USA. The Company’s immediate focus is the development and commercialization of biochip-based detection platforms for ultra-high sensitivity diagnostics and bioanalytical applications. Our culture represents innovative, driven, and talented professionals with diverse perspectives, but one which is united on a mission to significantly and positively make a difference in healthcare.